Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.
- NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_assertion description "[This study further provides a basis for clinical studies of the antisense oligonucleotide targeted to the RIalpha subunit of PKA (GEM 231) as a cancer therapeutic agent used alone or in combination with conventional chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.
- NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_assertion evidence source_evidence_literature NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.
- NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_assertion SIO_000772 10570186 NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.
- NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_assertion wasDerivedFrom befree-20150227 NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.
- NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_assertion wasGeneratedBy ECO_0000203 NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP900824.RAxoyBtgyPcygCuGXekSv1_OzomoeIdjxSBKuB9g79oXU130_provenance.